Atlas Trials

Total Neoadjuvant 6 Cycles of Chemotherapy Versus 3 Cycles in Partial Responder Patients Diagnosed With Epithelial Ovarian Cancer

Clinical trial NCT06980545 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06980545
Sponsor
Assiut University
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Stage III and IV Ovarian Cancer
Start date
2025-06-30
Primary completion
2026-04-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.